Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Exercise benefits heart and blood sugar
Wed Jan 16th - Cardiology experts have published a position paper urging doctors to prescribe exercise for people with type 2 diabetes and cardiovascular disease. More
Breast cancer risk calculator unveiled
Wed Jan 16th - A new method of calculating breast cancer risk is to be available for wide use by primary care practitioners and genetic counsellors, it has been announced. More
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...

NHS genomics project “at risk” - MPs

Friday April 20th, 2018

Ambitious plans to make the NHS a world leader in genomics are at risk, MPs warn today.

Delays in digital infrastructure and cuts to training budgets are holding back the deployment of the UK’s “world-leading” genomics capabilities, according to the Science and Technology Committee of the House of Commons.

It also risks losing public support through a lack of public awareness of its benefits, MPs found.

The UK has the 100,000 Genomes Project – but the medical community “remains to be convinced” it can replace existing diagnostics procedures for conditions such as common cancers, the MPs say. In contrast the case for using whole genome sequencing for rare diseases and some cancers is “compelling,” they say.

So far some 50,000 genomes have been sequenced for the project, the MPs heard – and work will now continue on this part of the project until the end of this year.

The MPs heard the optimal balance between whole genome sequencing and alternative genomic tests was not always clear.

There are also ethical concerns over the collection and use of patient data, they say.

The report says that genomics should be embedded in all relevant training courses and medical revalidation processes.

Committee chair Norman Lamb said: “We are concerned that the NHS’s delayed digital infrastructure projects will slow down the roll out of genomics in the UK.

“We are calling on the Government to continue, and increase, its investment in this area and allocate specific funding to the necessary genomics technology and systems.”

He added: “The UK is a world leader in genomics, and the establishment of a Genomics Medicine Service could dramatically improve health outcomes of UK citizens.

“Genomics has the potential to revolutionise NHS healthcare, but we are concerned that this potential is threatened by delays in the NHS’ digital projects, reduced genomics training budgets, and potential public concerns over sharing personal health data.”

Tags: Cancer | Genetics | NHS | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)